PAA 4.44% 21.5¢ pharmaust limited

2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD, page-90

  1. 1,401 Posts.
    lightbulb Created with Sketch. 986
    Sort of begs the question, why wouldn't you? Hey Cashtrain.
    The other thing I'm thinking is that when we FINALLY get to the phase 3 trial and MPL is offered as a combo with another standard of care drug the prognosis for OST improves even more. The vet gets to offer their tried and trusted treatment with a dose of free MPL on the side. I reckon this should really help with recruitment, which of course we'll need for the larger phase 3. We still need that BP or VM name behind us though with a fat cheque book and lots of clout. So IMO let's get this phase 2 done and dusted already, even if we don't get SD in 18 dogs surely VM wants to be able to sell their wares to pet patients for twice as long as they currently do? It's a combo treatment so they'll continue to sell their current drug with a extra fee for the MPL as well. AND for twice as long! A no brainer as far as I can see. VM are not daft so IMO RA and VM are currently now just haggling on price and VM are playing hardball knowing that we are short of cash and they certainly aren't.

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.5¢
Change
-0.010(4.44%)
Mkt cap ! $95.68M
Open High Low Value Volume
22.0¢ 22.0¢ 21.3¢ $125.5K 578.7K

Buyers (Bids)

No. Vol. Price($)
6 144480 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 318615 3
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.